Lawbrokr Launches Lawbrokr Enterprise and AI-Marketing Assistant to Improve Digital Intake
Lawyer.com is the first to pilot Lawbrokr Enterprise to enhance workflows TORONTO–(BUSINESS WIRE)–Lawbrokr, a legal technology company focused on client... Read more.
Checkmarx One Achieves Unprecedented Enterprise Adoption and Over $150M ARR in Three Years Under New Leadership
Company pioneers new AI Code Security Assistant category with Developer Assist and delivers groundbreaking research as platform grows PARAMUS, N.J.–(BUSINESS... Read more.
IonQ Achieves Top 10 Ranking in Prestigious Fortune Future 50 List of Global Enterprise Companies
IonQ is the only quantum company in the world to be included on distinguished list Recognition highlights confidence in IonQ’s ability to grow in dynamic markets... Read more.
Precision BioSciences Announces Publication in Nucleic Acids Research Elucidating the Mechanisms for High Efficiency Gene Insertion in Dividing and Non-Dividing Cells Using ARCUS Nucleases
– Publication describes how the unique qualities of ARCUS nucleases contribute to precise and efficient gene editing for gene insertion, single base editing,... Read more.
FiscalNote Launches CQ&A, a New Live Briefing Series Offering Subscribers Direct Access to CQ and Roll Call Journalists
CQ&A exclusively connects clients with Capitol Hill’s most trusted journalists for real-time insights and expert analysis of the rapidly shifting policy landscape.... Read more.
Neurogene Announces Positive Regulatory Update for NGN-401 Gene Therapy in Rett Syndrome with Plans to Initiate Dosing in Embolden™ Registrational Trial in Q4 2025
Completed discussions with FDA on registrational protocol; 13 sites to allow for rapid enrollment New preclinical data at ESGCT Congress highlight NGN-401 best-in-class... Read more.
Outpost24 Appoints Martin Roth as Chief Technology Officer to Advance Global Engineering and Innovation
Roth will lead technology strategy and engineering excellence to support Outpost24’s next phase of growth. STOCKHOLM & PHILADELPHIA–(BUSINESS WIRE)–Outpost24,... Read more.
Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025
Positive survival data from KEYNOTE-905 and KEYNOTE-B96 to be featured in Presidential Symposium, underscoring the impact of KEYTRUDA® (pembrolizumab) in certain... Read more.
Helen of Troy Limited Reports Second Quarter Fiscal 2026 Results
Consolidated Net Sales Decline of 8.9%GAAP Diluted Loss Per Share of $13.44Adjusted Diluted EPS of $0.59 (1) Provides Fiscal 2026 Outlook:Consolidated Net Sales... Read more.
MAC Copper Limited Announces Court Sanctions Scheme with Harmony
ST. HELIER, Jersey–(BUSINESS WIRE)–MAC Copper Limited ARBN 671 963 198 (NYSE:MTAL; ASX:MAC) MAC Copper Limited (NYSE:MTAL, ASX:MAC) (“MAC” or the... Read more.